Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab maintenance in metastatic colorectal cancer
NCT00952029Phase 3Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Mar 2010
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in colorectal cancer (metastatic) (mCRC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Mar 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00952029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952029.